UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

The New England journal of medicine, 2017-03, Vol.376 (10), p.917-927

2017

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Blood, 2008-04, Vol.111 (8), p.4022-4028

2008

Volltextzugriff (PDF)

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis

Blood, 2011-02, Vol.117 (6), p.1817-1821

2011

Volltextzugriff (PDF)

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

Blood, 2014-06, Vol.123 (24), p.3832-3842

2014

Volltextzugriff (PDF)

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

Blood, 2010-09, Vol.116 (9), p.1498-1505

2010

Volltextzugriff (PDF)

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia

Haematologica (Roma), 2016-08, Vol.101 (8), p.932

2016

Volltextzugriff (PDF)

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Leukemia, 2013-06, Vol.27 (6), p.1416-1418

2013

Volltextzugriff (PDF)

FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model

Blood, 2005-06, Vol.105 (12), p.4792-4799

2005

Volltextzugriff (PDF)

Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

Haematologica (Roma), 2014-10, Vol.99 (10), p.e179

2014

Volltextzugriff (PDF)

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

Leukemia, 2016-01, Vol.30 (1), p.112-123

2016

Volltextzugriff (PDF)

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Annals of oncology, 2007-10, Vol.18 (10), p.1673-1679

2007

Volltextzugriff (PDF)

Peptide length and folding state govern the capacity of staphylococcal β‐type phenol‐soluble modulins to activate human formyl‐peptide receptors 1 or 2

Journal of leukocyte biology, 2015-04, Vol.97 (4), p.689-697

2015

Volltextzugriff (PDF)

Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300

Haematologica (Roma), 2023-02, Vol.108 (2), p.490

2023

Volltextzugriff (PDF)

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

The Lancet (British edition), 2002-02, Vol.359 (9305), p.487-491

2002

Volltextzugriff (PDF)

Interstitial lung opacities in patients with severe COVID-19 pneumonia by bedside high-resolution ultrasound in association to CO2 retention

Clinical hemorheology and microcirculation, 2021-01, Vol.77 (4), p.355

2021

Volltextzugriff (PDF)

Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma

Radiotherapy and oncology, 2009-11, Vol.93 (2), p.185-191

2009

Volltextzugriff (PDF)

Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor

Blood, 2003-07, Vol.102 (2), p.646-651

2003

Volltextzugriff (PDF)

Contrast enhanced ultrasonography (CEUS) a novel tool to detect intestinal epithelial barrier dysfunction in severe COVID-19 disease

Clinical hemorheology and microcirculation, 2022-01, Vol.81 (2), p.177

2022

Volltextzugriff (PDF)

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma

Blood, 2014-09, Vol.124 (13), p.2081-2090

2014

Volltextzugriff (PDF)

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

Leukemia, 2003-05, Vol.17 (5), p.829-838

2003

Volltextzugriff (PDF)

Grb10 is involved in BCR-ABL-positive leukemia in mice

Leukemia, 2015-04, Vol.29 (4), p.858-868

2015

Volltextzugriff (PDF)

Klinische Praxis und Ergebnisse der neoadjuvanten Chemotherapie bei frühem Brustkrebs: Analyse der Daten von 94.638 Patienteninnen aus 55 zertifizierten Brustkrebszentren

Forum (Heidelberg), 2022-12, Vol.37 (6), p.479-481

2022

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

KollektionWiley Online Library Full Collection 2018

PublikationsformArtikel

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(104)

Sprache

Englisch
(121)
Japanisch
(22)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(117)
Life Sciences & Biomedicine
(116)
Humans
(95)
Oncology
(55)
Biological And Medical Sciences
(43)
Medical Sciences
(37)
Animals
(34)
Female
(28)
Mice
(28)
Male
(27)
Hematologic And Hematopoietic Diseases
(25)
Leukemia
(23)
Middle Aged
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(21)
Cells, Cultured
(20)
Adult
(18)
Aged
(18)
Imatinib Mesylate
(17)
Benzamides
(16)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(32)
Leukemia
(25)
Experimental Hematology
(11)
Leukemia & Lymphoma
(11)
Haematologica
(7)
Stem Cells
(4)
Bone Marrow Transplantation
(3)
Clinical Hemorheology And Microcirculation
(3)
Blood Cancer Journal
(2)
Circulation Research
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model

Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Peptide length and folding state govern the capacity of staphylococcal β‐type phenol‐soluble modulins to activate human formyl‐peptide receptors 1 or 2

Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

Interstitial lung opacities in patients with severe COVID-19 pneumonia by bedside high-resolution ultrasound in association to CO2 retention

Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma

Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor

Contrast enhanced ultrasonography (CEUS) a novel tool to detect intestinal epithelial barrier dysfunction in severe COVID-19 disease

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

Grb10 is involved in BCR-ABL-positive leukemia in mice

Klinische Praxis und Ergebnisse der neoadjuvanten Chemotherapie bei frühem Brustkrebs: Analyse der Daten von 94.638 Patienteninnen aus 55 zertifizierten Brustkrebszentren

Aktive Filter

Suchergebnisse filtern